Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety

Q: What does this research mean for the field?

Hematopoietic stem cell transplantation (HSCT) drastically improves survival and slows deterioration in patients with CSF1R-related disorder (CSF1R-RD). Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Tomasz Tomasz; Kamila Żur-Wyrozumska; Patrycja Mensah-Glanowska; Audrey Strongosky; Erik H. Middlebrooks; Ernesto Ayala; Zbigniew K. Wszolek

doi:10.14802/jmd.26005

February 27, 2026Journal of Movement DisordersOpen Access

Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate the efficacy and safety of hematopoietic stem cell transplantation in treating CSF1R-related disorder.
Conducted a longitudinal study
Evaluated disease-modifying effects of HSCT
Measured survival rates and quality of life improvements
HSCT significantly improved survival rates
Quality of life was greatly preserved
Early intervention during the symptomatic phase is crucial

Implication

Longitudinal study finds early HSCT improves survival and quality of life in CSF1R-related disorder, suggesting timely interventions are crucial.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Tomasz et al. (2026) studied this question.

synapsesocial.com/papers/69a3d79dec16d51705d2dde8 https://doi.org/10.14802/jmd.26005

View Full Paper

Ask AI

Bookmark

Share

Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety

Key Points

Implication

Discussion

Cite This Study

Hematopoietic Stem Cell Transplantation for CSF1R-Related Disorder: A Longitudinal Study of Efficacy and Safety

Key Points

Implication

Discussion

Cite This Study

Keep reading

Keep reading